Dana-Farber Cancer Institute’s Chemical Biology Program is an internationally recognized center of excellence in cancer research, with a focus on unanswered biological questions and clinical challenges. Watch as Dana-Farber’s Chief Scientific Officer, Kevin Haigis, PhD, moderates a discussion with Sara Buhrlage, PhD, Eric Fischer, PhD, and Loren Walensky, MD, PhD, on the rapidly evolving area of cancer chemical biology.